MIR31HG and non-small cell lung carcinoma: MIR31HG is a direct target of miR-214 in non-small cell lung cancer (NSCLC) [10], and miR-214 promotes inflammation and immunity in several systems, such as organ transplant and immune tolerance [15, 16].